Lafadofensine (INNTooltip International Nonproprietary Name), also known as (3S)-N,N-bis(4-fluorophenyl)pyrrolidin-3-amine, is a drug described as an antidepressant which has not been marketed at this time. It is said to act as a serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI). The drug was first described by 2010 and its INNTooltip International Nonproprietary Name was proposed by 2021.
See also List of investigational antidepressants 2-Diphenylmethylpyrrolidine Desoxypipradrol
References


